Shareholder’s Equity - Schedule of Activities Share Options (Details) - USD ($)			12 Months Ended
Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2025	Jun. 30, 2024
Schedule of Activities Share Options [Abstract]
Number of Share Options, Outstanding Beginning (in Shares)		30,400,304	28,673,014
Weighted Average Exercise Price, Outstanding Beginning		$ 0.26	$ 0.26
Weighted Average Grant-date Fair value ,Outstanding Beginning		$ 0.15	$ 0.15
Weighted Average Remaining Contractual Term, Outstanding Beginning		8 years 21 days	6 years 1 month 28 days	7 years 21 days
Aggregate Intrinsic Value, Outstanding Beginning (in Dollars)		$ 10,608,693	$ (4,856,370)
Number of Share Options, Granted (in Shares)	592,230
Weighted Average Exercise Price, Granted	$ 17.4
Weighted Average Grant-date Fair value , Granted	$ 10.39
Weighted Average Remaining Contractual Term, Granted	10 years
Aggregate Intrinsic Value, Granted (in Dollars)	$ (213,203)
Number of Share Options, Expired, forfeited or cancelled (in Shares)			(4,774,738)	(1,727,290)
Weighted Average Exercise Price, Expired, forfeited or cancelled			$ 0.25	$ 0.25
Weighted Average Grant-date Fair value, Expired, forfeited or cancelled			$ 0.14	$ 0.14
Weighted Average Remaining Contractual Term, Expired, forfeited or cancelled			6 years 6 months 18 days
Aggregate Intrinsic Value, Expired, forfeited or cancelled (in Dollars)			$ (11,393,123)
Number of Share Options, Outstanding ending (in Shares)	28,673,014		24,490,506	28,673,014
Weighted Average Exercise Price, Outstanding Ending	$ 0.26		$ 0.68	$ 0.26
Weighted Average Grant-date Fair value ,Outstanding Ending	$ 0.15		$ 0.4	$ 0.15
Weighted Average Remaining Contractual Term, Outstanding Ending		8 years 21 days	6 years 1 month 28 days	7 years 21 days
Aggregate Intrinsic Value, Outstanding Ending (in Dollars)	$ (4,856,370)		$ 440,464,693	$ (4,856,370)
Number of Share Options, Exercisable (in Shares)			18,543,582
Weighted Average Exercise Price, Exercisable			$ 0.25
Weighted Average Grant-date Fair value , Exercisable			$ 0.15
Weighted Average Remaining Contractual Term, Exercisable			6 years 2 months 15 days
Aggregate Intrinsic Value, Exercisable (in Dollars)			$ 315,665,450
Number of Share Options, Vested and Expected to Vest (in Shares)			24,490,506
Weighted Average Exercise Price,Vested and Expected to Vest			$ 0.68
Weighted Average Grant-date Fair value, Vested and Expected to Vest			$ 0.4
Weighted Average Remaining Contractual Term, Vested and Expected to Vest			6 years 1 month 28 days
Aggregate Intrinsic Value, Vested and Expected to Vest (in Dollars)			$ 440,464,693

Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition.

No definition available.